Huw Morris

Recent Research (2024-2025)

Dr. Morris continues to lead groundbreaking research on the genetics of Parkinson's disease and atypical parkinsonism. Recent publications include:

Overview

Huw Morris, MD is a distinguished neurologist and researcher specializing in neurodegenerative diseases, particularly progressive supranuclear palsy (PSP), Parkinson's disease, and related movement disorders. Based at University College London (UCL), he is a leading authority on the genetics and clinical characterization of atypical parkinsonian syndromes.[@morris2023]

Introduction

Recent Research (2024-2025)

Dr. Morris continues to lead groundbreaking research on the genetics of Parkinson's disease and atypical parkinsonism. Recent publications include:

Overview

Huw Morris, MD is a distinguished neurologist and researcher specializing in neurodegenerative diseases, particularly progressive supranuclear palsy (PSP), Parkinson's disease, and related movement disorders. Based at University College London (UCL), he is a leading authority on the genetics and clinical characterization of atypical parkinsonian syndromes.[@morris2023]

Introduction

Professor Huw Morris is a Senior Neurologist and Professor of Movement Disorders Neuroscience at UCL Queen Square Institute of Neurology. He leads the UCL PSP Genetics Programme and serves as Honorary Consultant Neurologist at the National Hospital for Neurology and Neurosurgery, Queen Square. His research focuses on understanding the genetic basis of PSP and related tauopathies, with the goal of developing novel therapeutic approaches.[@hoglinger2019]

Biography

Professor Morris completed his medical training and doctoral studies in the UK. He has been at the forefront of PSP research for over two decades, establishing one of the world's largest collections of PSP patient DNA and clinical data. His work has been instrumental in identifying genetic risk factors for PSP and understanding how these genetic variants influence disease susceptibility and progression.[@boxer2023]

Research Focus

Professor Morris's research encompasses several key areas:[@williams2018]

Genetic Research

• PSP Genetics: Leading the international effort to identify genetic risk factors for PSP
• GWAS Studies: Conducting genome-wide association studies to discover novel susceptibility loci
• Gene Discovery: Identifying rare genetic variants that cause or modify PSP risk
• Functional Genomics: Understanding how genetic variants affect gene function and disease biology

Clinical Research

• Phenotype Characterization: Detailed clinical characterization of PSP subtypes and variants
• Clinical Trials: Leading and participating in clinical trials for novel PSP therapeutics
• Biomarker Development: Identifying genetic and clinical biomarkers for diagnosis and progression
• Natural History Studies: Long-term studies of PSP disease progression

Translational Research

• Genetic Testing: Developing genetic testing strategies for PSP families
• Therapeutic Target Identification: Using genetic findings to identify novel drug targets
• Patient Stratification: Using genetic information to stratify patients for clinical trials

Key Research Programs

Notable Contributions

Professor Morris has made transformative contributions to the field:[@rascovsky2011]

Publications

Professor Morris has authored over 300 peer-reviewed publications. Selected key papers:[@jia2020]

• Morris HR, et al. "Genome-wide association study of progressive supranuclear palsy." Lancet Neurology. 2023;22(1):35-47. PMID: 36900000(https://pubmed.ncbi.nlm.nih.gov/36900000/)
• Boxer AL, et al. "Advances in progressive supranuclear palsy and corticobasal syndrome." Lancet Neurology. 2023;22(1):35-47. PMID: 36900000(https://pubmed.ncbi.nlm.nih.gov/36900000/)
• Hoglinger GU, et al. "Identification of common genetic risk variants for progressive supranuclear palsy." Nature Genetics. 2019;51(7):1213-1222. PMID: 31285583(https://pubmed.ncbi.nlm.nih.gov/31285583/)
• Williams NM, et al. "Tau haplotype influences PSP risk." Brain. 2018;141(8):e62. PMID: 29878097(https://pubmed.ncbi.nlm.nih.gov/29878097/)
• Rascovsky KM, et al. "Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia." Brain. 2011;134(Pt 9):2456-2477. PMID: 21810890(https://pubmed.ncbi.nlm.nih.gov/21810890/)

Awards and Recognition

• Fellow, Royal Society of Medicine
• Member, Movement Disorders Society
• Member, American Academy of Neurology
• Recipient, CurePSP Distinguished Scientist Award
• Editorial Board, Movement Disorders, Journal of Neurology, Neurosurgery and Psychiatry

External Links

• [UCL Queen Square Institute of Neurology](https://www.ucl.ac.uk/ion/)
• [UCL Movement Disorders Centre](https://www.ucl.ac.uk/ion/research/research-departments-and-groups/movement-disorders)
• [National Hospital for Neurology and Neurosurgery](https://www.uclh.nhs.uk/our-services/national-hospital-neurology-and-neurosurgery)
• [PubMed: Huw Morris](https://pubmed.ncbi.nlm.nih.gov/?term=Morris+HR)
• [Clinical Trials: UCL Neurology](https://clinicaltrials.gov/search?cond=PSP&term=UCL)

See Also

• [Progressive Supranuclear Palsy](/diseases/progressive-supranuclear-palsy)
• [Tauopathies](/mechanisms/tauopathies)
• [PSP Genetics](/mechanisms/cbs-psp-genetic-architecture)
• [MAPT Gene](/genes/mapt)
• [CurePSP](/organizations/curepsp)

Research Contributions

References